Post by Gerresheimer

Gerresheimer has published its 2025 annual and consolidated financial statements, delivering a clear signal of transparency and compliance to our customers, partners, and investors. 𝗞𝗲𝘆 𝗙𝗶𝗴𝘂𝗿𝗲𝘀 𝗙𝗬 𝟮𝟬𝟮𝟱 • Revenue: EUR 2.3 bn • Adjusted EBITDA: EUR 384 m • Organic revenue growth: +0.3% • Adjusted EBITDA margin: 16.8% 🔗 Read our Corporate News here: https://lnkd.in/eTWdubEt #Pharma #Biotech #Cosmetics #Sustainability #DrugDelivery #AnnualReport2025 #Gerresheimer #innovatingforabetterlife